Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROSE-TNK: Tenecteplase for Stroke Beyond Time Window
NCT04752631Phase 4Completed
- Sponsor
- General Hospital of the Northern Theater Command
- Start
- Mar 2021
- Primary completion
- Jul 2022
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of tenecteplase in ischemic stroke, sponsored by General Hospital of the Northern Theater Command. Started Mar 2021; status: completed.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT04752631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04752631.